HGAL is a novel interleukin-4–inducible gene that strongly predicts survival in diffuse large B-cell lymphoma
Year: 2002
Type: article
Study design: Observational Study
Source: Blood
Institutions: Stanford Medicine, Stanford University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2057068754
